Web Analytics

3 Latest Announced Rounds

  • $10,600,000
    Pre-Seed

    5 Investors

    Technology, Information and Internet
    Jun 6th, 2025
  • $13,702,071
    Series A

    3 Investors

    Insurance
    Jun 6th, 2025
  • $15,000,000
    Unknown

    1 Investors

    Biotechnology Research
    Jun 6th, 2025
$863.23M Raised in 46 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Ankyra Therapeutics

start up
United States - Boston, Massachusetts
  • 12/11/2021
  • Series B
  • $45,000,000

Developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response


Related People

Howard KaufmanFounder

Howard Kaufman United States - Boston, Massachusetts

Experienced Chief Medical Officer with a demonstrated history of working in academic medicine and the biotechnology industry. Skilled in Cancer Research, Biotechnology, Healthcare Management, Healthcare, and Life Sciences. Strong healthcare services professional with considerable expertise in cancer immunotherapy and drug development.